References
1. White NJ, Pukrittayakamee S, Hien TT, Faiz MA, Mokuolu OA, Dondorp AM. Malaria. Lancet. 2014;383(9918):723-35. 2. Franco JR, Simarro PP, Diarra A, Jannin JG. Epidemiology of human African trypanosomiasis. Clin Epidemiol. 2014;6:257-75. 3. McManus DP, Dunne DW, Sacko M, Utzinger J, Vennervald BJ, Zhou XN. Schistosomiasis. Nat Rev Dis Primers. 2018;4(1):13. 4. Keiser J, Utzinger J. The drugs we have and the drugs we need against major helminth infections. Adv Parasitol. 2010;73:197-230. 5. Hicks MI, Elston DM. Scabies. Dermatol Ther. 2009;22(4):279-92. 6. Barry JD, McCulloch R. Antigenic variation in trypanosomes: enhanced phenotypic variation in a eukaryotic parasite. Adv Parasitol. 2001;49:1-70. 7. Acosta-Serrano A, Gonzalez-Prieto L, De Souza J, et al. Host-parasite interactions in African trypanosomiasis. Adv Parasitol. 2007;65:215-50. 8. Pearce EJ, MacDonald AS. The immunobiology of schistosomiasis. Nat Rev Immunol. 2002;2(7):499-511. 9. World Health Organization. World malaria report 2020: 20 years of global progress and challenges. Geneva: WHO; 2020. 10. Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet. 2014;383(9936):2253-64. 11. Alvar J, Velez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7(5) 12. Bern C. Chagas' disease. N Engl J Med. 2015;373(5):456-66. 13. Polley SD, González IJ, Mohamed D, et al. Clinical evaluation of a nested PCR test for the diagnosis of malaria. PLoS One. 2013;8(12) 14. McCormick JA, Sturrock RF. Diagnosis of Schistosomiasis. In: Weatherall DJ, Ledingham JGG, Warrell DA, editors. Oxford Textbook of Medicine. Oxford: Oxford University Press; 2016. p. 2914-21. 15. Ritchie TL. Molecular diagnosis of parasitic infections. Clin Microbiol Rev. 2006;19(1):112-34. 16. Imwong M, Pouplin T, Aksornneam P, et al. Evaluation of a rapid diagnostic test for malaria in a field setting in Thailand. Malar J. 2005;4:13. 17. Dondorp AM, Nosten F, Yi P, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361(5):455-67. 18. Vercruysse J, Albonico M, Engels D, et al. The role of mass drug administration in the control of soil-transmitted helminthiasis. Acta Trop. 2011;120 Suppl 1. 19. Berman JD. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis. 1997;24(4):684-703. 20. Hotez PJ, Kamath A. Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis. 2009;3(8). 21. World Health Organization. Vector control for malaria and other mosquito-borne diseases. Geneva: WHO; 2017. 22. Strunz EC, Addiss DG, Stocks ME, et al. Water, sanitation, hygiene, and soiltransmitted helminth infection: a systematic review and meta-analysis. PLoS Med. 2014;11(3)23. Rebollo MP, Bockarie MJ. Towards the elimination of lymphatic filariasis by 2020: advances in mass drug administration, monitoring, and surveillance. Ann N Y Acad Sci. 2017;1399(1):16-29. 24. RTS,S Clinical Trials Partnership. Efficacy and safety of RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites. PLoS Med. 2014;11(7). 25. Hotez PJ, Molyneux DH, Fenwick A, et al. Rescuing the bottom billion through control of neglected tropical diseases. Lancet. 2009;373(9674):1570-5. 26. de Monbrison A, Nosten F, Vanderberg JP. Antimalarial drug resistance and its molecular mechanisms. In: Su XZ, editor. Malaria: a textbook. Oxford: Oxford University Press; 2013. p. 344-68. 27. Hotez PJ, Molyneux DH, Fenwick A, et al. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Negl Trop Dis. 2006;1(1). 28. Molyneux DH, Hall A. Integrating neglected tropical diseases into global health and development agendas. Lancet. 2014;384(9953):335-7. 29. Patz JA, Confalonieri U, de Wet N, et al. Climate change and infectious diseases. In: Morse SS, editor. Emerging infections. Washington, D.C.: ASM Press; 2004. p. 177- 95. 30. Alonso PL, Smith PA, Mendis C, Chitnis C. The RTS,S/AS01 malaria vaccine: a new era in malaria vaccine development. Expert Rev Vaccines. 2014;13(11):1271-82. 31. Gilleard JS, Beech RN. Anthelmintic resistance in nematodes of veterinary importance: lessons learned from the livestock sector. Trends Parasitol. 2007;23(7):320-7. 32. Gurdasani D, Richardson D, Chaudhury S, et al. The role of AI in infectious disease management and surveillance. Trends Infect Dis. 2023;1(1):10-22. 33. Molyneux DH, Neglected tropical diseases and integrated control: a vision for the future. In: de Silva NR, editor. Integrated control of neglected tropical diseases. Cambridge: Cambridge University Press; 2020. p. 221-38.
